貝瑞基因(000710.SZ):Xcelom擬增發股份對其總經理周代星在任期內實施股權激勵
格隆匯3月23日丨貝瑞基因(000710.SZ)公佈,公司控股子公司HongKong Berry Genomics Co., Limited的控股子公司Xcelom Limited(“Xcelom”)為公司境外業務發展平台,為進一步加快境外業務發展節奏,Xcelom於近日召開董事會審議通過了聘任ZHOUDAIXING(周代星)為總經理,任期三年的議案。該議案不改變ZHOUDAIXING(周代星)在公司的任職,ZHOUDAIXING(周代星)擔任公司總經理同時兼任Xcelom總經理。
Xcelom擬通過增發股份的方式對其總經理ZHOUDAIXING(周代星)在任期內實施股權激勵。公司放棄對Xcelom此次激勵增發股份的認繳出資權,不涉及公司放棄控制權及導致公司合併報表範圍發生變更的情形。
ZHOUDAIXING(周代星)曾任美國康寧公司項目經理、美國Lynx/Solexa公司生物信息部經理、美國Illumina公司亞太日本區測序銷售總監、美國Life Technologies公司全球測序部市場發展總監。ZHOUDAIXING(周代星)是全球早期參與二代基因測序技術開發的主要成員,多年來一直致力於在全球範圍內商業化推廣測序技術,開發並將無創產前檢測技術引入中國,作為公司創始人之一,具有豐富的基因測序行業經驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.